pramipexole has been researched along with ropinirole in 157 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (ropinirole) | Trials (ropinirole) | Recent Studies (post-2010) (ropinirole) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 637 | 129 | 243 |
| Protein | Taxonomy | pramipexole (IC50) | ropinirole (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Bos taurus (cattle) | 6.81 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (9.55) | 18.2507 |
| 2000's | 76 (48.41) | 29.6817 |
| 2010's | 60 (38.22) | 24.3611 |
| 2020's | 6 (3.82) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Allerton, CM; Batchelor, DV; Baxter, AD; Blagg, J; Burring, DJ; Carr, CL; Cook, AS; Nichols, CL; Phipps, J; Sanderson, VG; Verrier, H; Wong, S | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Antonio, T; Dutta, AK; Gopishetty, B; Kharkar, PS; Reith, M; Zhang, S | 1 |
| Alvarado, M; Brea, J; Carro, L; Iglesias, A; Insua, I; Loza, MI; Masaguer, CF | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dengler, D; Gmeiner, P; Hübner, H; Männel, B; Möller, D; Shonberg, J | 1 |
| Rabey, JM | 1 |
| Heins, JR | 1 |
| Wienkers, LC; Wynalda, MA | 1 |
| Alldredge, BK; Aminoff, MJ; Bainbridge, JL; Dowling, GA; Gottwald, MD | 1 |
| LeWitt, PA | 2 |
| Fernandez, HH; Friedman, JH | 1 |
| Lange, KW | 1 |
| Factor, SA | 1 |
| Fahn, S; Frucht, S; Gordon, MF; Greene, PE; Rogers, JD | 1 |
| Hobson, DE; Martin, WR; Pourcher, E | 1 |
| Phillips, P | 1 |
| Weiner, WJ | 2 |
| Montastruc, JL; Rascol, O; Senard, JM | 1 |
| Olanow, CW; Roth, T; Schapira, AH | 2 |
| Hoehn, MM | 1 |
| Lledó, A; Nash, J | 1 |
| Arellano, FM; Corrigan, M | 1 |
| Arnold, G | 1 |
| Bliwise, DL; Rye, DB | 1 |
| Lam, YW | 1 |
| Ryan, M; Slevin, JT; Wells, A | 1 |
| Cassel, W; Krüger, HP; Möller, JC; Oertel, WH; Peter, JH; Stiasny, K | 1 |
| Blasucci, L; Goetz, CG; Kujawa, K; Leurgans, S; Raman, R | 1 |
| Brannan, T; Prikhojan, A; Yahr, MD | 1 |
| Sternon, J; Supiot, F; Zegers de Beyl, D | 1 |
| Cullen, N; Lexell, J; Zafonte, RD | 1 |
| Moller, H | 1 |
| Ernst, ME; Weimerskirch, PR | 1 |
| Jankovic, J; Le, WD | 1 |
| Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A | 1 |
| Akiskal, H; Frare, F; Perugi, G; Ruffolo, G; Toni, C | 1 |
| Etminan, M; Rochon, PA; Samii, A; Takkouche, B | 1 |
| Di Rocco, A; Tabamo, RE | 1 |
| Montgomery, EB | 1 |
| Gekht, AB | 1 |
| Crevenna, R; Homann, CN; Ivanic, G; Ott, E; Suppan, K; Wenzel, K | 1 |
| Jennings, D; Marek, K; Seibyl, J | 1 |
| Clarke, CE; Guttman, M | 1 |
| Reichmann, H | 1 |
| Berardelli, A; De Pandis, MF; Modugno, N; Ruggieri, S; Stocchi, F; Thomas, A; Vacca, L; Valente, M | 1 |
| Etminan, M; Gill, S; Samii, A | 1 |
| MacMahon, DG | 1 |
| Bankowski, BJ; Zacur, HA | 1 |
| Morrish, PK | 1 |
| Inzelberg, R; Nisipeanu, P; Schechtman, E | 1 |
| Corsini, GU; Maggio, R; Millan, MJ; Novi, F; Scarselli, M | 1 |
| Borwege, S; Hagner, D; Joyce, JN; Millan, MJ; Osredkar, T; PazSoldan, M; Presgraves, S; Renish, L; Replogle, M | 1 |
| Lang, AE; Razmy, A; Shapiro, CM | 1 |
| Jankovic, J; Le, W; Pan, T | 1 |
| Grosset, D; Grosset, K; Macphee, G; Needleman, F | 1 |
| Cassel, W; Haja, D; Körner, Y; Krüger, HP; Meindorfner, C; Möller, JC; Oertel, WH; Stiasny-Kolster, K | 1 |
| Bara-Jimenez, W; Chase, TN; Dimitrova, T; Favit, A; Mouradian, MM; Sherzai, A | 1 |
| Silber, MH | 1 |
| Boggie, DT; Chan, H; Delattre, ML; Morreale, AP; Plowman, BK; Schaefer, MG | 1 |
| Kurlan, R | 1 |
| Althoff, R; Jacobson, J; Martineau, RJ; Singh, A | 1 |
| Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
| Ahlskog, JE; Bower, JH; Josephs, KA; Klos, KJ; Matsumoto, JY | 1 |
| Stocchi, F | 1 |
| Schapira, AH | 1 |
| Du, F; Huang, Y; Le, W; Li, R; Li, X | 1 |
| Duda, JE; Goveas, J; Moberg, PJ; Morales, KH; Potenza, MN; Siderowf, AD; Stern, MB; Weintraub, D | 1 |
| Fuhrmann, JT; Junghanns, S; Koch, R; Oelwein, C; Reichmann, H; Simonis, G; Storch, A; Strasser, RH | 1 |
| Anzellotti, F; Bonanni, L; D'Andreagiovanni, A; Di Iorio, A; Onofrj, M; Stocchi, F; Thomas, A; Varanese, S | 1 |
| Dewey, RB; O'Suilleabhain, PE; Reimold, SC | 1 |
| Allen, RP; Hening, W; Tenzer, P; Winkelman, JW | 1 |
| Hornyak, M; Spiegelhalder, K | 1 |
| Abrams, KR; Finnern, HW; Lleu, PL; Martin, M; Nicolas, A; Petit, C; Quilici, S | 1 |
| Ball, E; Caivano, CK | 1 |
| Thomas, K; Watson, CB | 1 |
| Arbouw, ME; Egberts, TC; Guchelaar, HJ; Movig, KL; Neef, C; Poels, PJ; van Vugt, JP | 1 |
| Bares, M; Krajcovicová, L; Rektor, I; Rektorová, I | 1 |
| DasGupta, R; Finnern, HW; Lees, M; Roberts, G; Tabberer, M | 1 |
| Andersohn, F; Garbe, E | 1 |
| Nijssen, PC; Weber, WE | 1 |
| Ferini-Strambi, L | 1 |
| Ahlskog, JE; Bostwick, JM; Bower, JH; Hecksel, KA; Stevens, SR | 1 |
| Bereczki, D; Bódi, N; Daw, N; Dibó, G; Gluck, MA; Kéri, S; Moustafa, A; Myers, CE; Nagy, H; Takáts, A | 1 |
| Grimm, C; Kirch, W; Köberlein, J; Nelles, S; Pittrow, D; Rychlik, R | 1 |
| Arbouw, ME; Egberts, TC; Guchelaar, HJ; Movig, KL; Neef, C; Poels, PJ; van der Straaten, RJ; van Vugt, JP; Wessels, JA | 1 |
| Cho, JY; Cho, YJ; Hong, KS; Jeon, BS; Kim, HJ; Lee, DH; Park, SY; Seo, SY | 1 |
| Ako-Agugua, N; Colasante, J; Hertweck, L; Houser, T; Nagar, S; Raffa, RB; Smith, J; Varga, LI; Watty, AA | 1 |
| Lyons, KE; Pahwa, R | 1 |
| Cornelius, JR; Frerichs, CF; Silber, MH; Slocumb, NL; Tippmann-Peikert, M | 1 |
| Bienfait, KL; Dobkin, RD; Mark, MH; Menza, M | 1 |
| Bergmann, L; Jost, WH | 1 |
| Koester, J; Lang, AE; Potenza, MN; Siderowf, AD; Stacy, M; Voon, V; Weintraub, D; Whetteckey, J; Wunderlich, GR | 1 |
| Bozi, M; Christodoulou, C; Douzenis, A; Gasparinatos, G; Stamboulis, E; Stefanis, C; Stefanis, L; Stefanis, N | 1 |
| Ahlskog, JE; Bower, JH; Fealey, RD; Hassan, A; Josephs, KA; Kumar, N; Matsumoto, JY | 1 |
| Bottasini, V; Ferini-Strambi, L; Ferri, R; Giarolli, L; Manconi, M; Oldani, A; Zucconi, M | 1 |
| Abe, H; Baba, Y; Fukuyama, K; Higuchi, MA; Inoue, T; Uehara, Y; Yamada, T | 1 |
| Allen, RP; Ball, E; Calloway, MO; Higbie, RL; Lee, MR; Manjunath, R; Nisbet, PA; Ondo, WG | 1 |
| Ahlskog, JE | 1 |
| Cripps, MG | 1 |
| Buttarelli, FR; Campanelli, D; Fanciulli, A; Misasi, R; Pontieri, FR | 1 |
| Calvo, E; de la Llave, Y; García-Borreguero, D; Granizo, JJ; Larrosa, O; Tzonova, D; Williams, AM | 1 |
| Tarrants, ML; Zagmutt, FJ | 1 |
| de Biase, S; Gigli, GL; Lorenzut, S; Merlino, G; Valente, M | 1 |
| Aurora, RN; Bista, SR; Casey, KR; Kristo, DA; Lamm, CI; Rosenberg, RS; Rowley, JA; Tracy, SL; Zak, RS | 1 |
| Asmus, F; Kaut, O; Paus, S | 1 |
| Daghem, M; Grosset, DG; Grosset, KA; Macphee, GJ; Newman, EJ; Nissen, T; Odin, P; Pal, G; Stewart, M | 1 |
| Sheehan, J; Thorpe, M; Wilson, L | 1 |
| Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ | 1 |
| Arnulf, I; Brion, A; Launois, C; Leu-Semenescu, S | 1 |
| Edelstyn, NM; Ellis, SJ; Mayes, AR; Shepherd, TA | 1 |
| Jeon, BS; Kim, HJ; Kim, JM; Kim, JS; Kim, YE; Lee, JY; Yun, JY | 1 |
| Bayard, S; Dauvilliers, Y; Langenier, MC | 1 |
| Gonzalez-Alegre, P; Lamichhane, D; Narayanan, NS | 1 |
| Amos, LB; Collins, MM; D'Andrea, LA; Grekowicz, ML; Kuhn, EM; Norins, NA; Olstad, JD | 1 |
| Snider, S | 1 |
| Alonso-Canovas, A; Garcia-Ruiz, PJ; Herranz Barcenas, A; Mahillo Fernandez, I; Martinez Castrillo, JC; Mata, M; Olmedilla Gonzalez, N; Sanchez Alonso, P; Vela, L | 1 |
| Bassetti, CL; Ferini-Strambi, L; Fulda, S; Maestri, M; Manconi, M; Marelli, S; Staedler, C; Zucconi, M | 1 |
| Peng, GG; Wang, M; Zhang, JW; Zhou, CQ | 1 |
| Morel, T; Sun, Y; van Valkenhoef, G | 1 |
| Cho, YW; Jeon, JY; Lee, HB; Moon, HJ; Song, ML | 1 |
| Glenmullen, J; Mattison, DR; Moore, TJ | 1 |
| Cauthon, KA; DeBacker, D; Lockett, K | 1 |
| Bauer, L; Chung, SJ; Ikeda, J; Jeon, BS; Kim, JM; Kim, JW; Singh, P; Thierfelder, S | 2 |
| Fernández-Bobadilla, R; Gironell, A; Kulisevsky, J; Martínez-Horta, S; Pagonabarraga, J; Pascual-Sedano, B; Pérez-Pérez, J; Sierra, S | 1 |
| Jankovic, J; Wijemanne, S | 1 |
| Hiratochi, M; Ijiro, T; Kaidoh, K; Oana, F; Suzuki, T; Tsuchioka, A; Yamauchi, Y | 1 |
| Contin, M; Mohamed, S; Riva, R | 1 |
| Antonini, A; Chaudhuri, KR; Durner, G; Falup-Pecurariu, C; Grilo, M; Henriksen, T; Kessel, B; Martinez-Martin, P; Odin, P; Rizos, A; Røkenes Karlsen, K; Sauerbier, A; Silverdale, M; Weintraub, D | 1 |
| Jo, J; Mousa, SA; Sahli, ZT; Tarazi, FI | 1 |
| Mackie, SE; Mei, LA; Platt, S; Schoerning, L; Winkelman, JW | 1 |
| Carleton, BC; Etminan, M; Guo, M; Procyshyn, RM; Samii, A; Sodhi, M | 1 |
| Ji, F; Jiang, R; Su, Z; Xue, R; Zhou, Y; Zhu, X; Zhuo, C | 1 |
| Castro-Martínez, XH; Feliz-Feliz, C; García-Ruiz, PJ; Hoenicka, J; Martínez-Castrillo, JC; Martínez-García, C; Martínez-Torres, I; Mata, M; Palau, F; Vela, L | 1 |
| Hartzema, AG; Kim, J | 1 |
| Bono, F; Cavalleri, L; Collo, G; Fedele, S; Gennarelli, M; Invernizzi, RW; Kunath, T; Merlo Pich, E; Millan, MJ; Mora, C; Piovani, G; Spano, P | 1 |
| Challet-Bouju, G; Derkinderen, P; Fève, JM; Grall-Bronnec, M; Le Moigne, M; Leboucher, J; Victorri-Vigneau, C | 1 |
| Doladé, NG; Figueras, A; García, GC; Lanteri, PF; Leguia, A | 1 |
| Allen, RP; Earley, CJ; Foster, K; Hiranniramol, K; Skeba, P; Wang, A | 1 |
| Baik, JS; Cho, J; Jeon, B; Kim, HT; Kim, JM; Kim, JW; Koh, SB; Kwon, OD; Lee, HW; Lee, JY; Ma, HI; Yoon, WT | 1 |
| Calandra-Buonaura, G; Capellari, S; Contin, M; Cortelli, P; De Massis, P; Lopane, G; Mohamed, S; Nassetti, S; Perrone, A; Riva, R; Sambati, L; Scaglione, C | 1 |
| Cooper, J; Ni, X; Ning, Y; Parks, D; Refoios Camejo, R; Yi, B; Zhao, H | 1 |
| Frampton, JE | 1 |
| Bortolato, M; Jeon, N | 1 |
| Håkansson, A; Wolfschlag, M | 1 |
| Ando, H; Doyu, M; Fujikake, A; Fukuoka, T; Hayashi, M; Ito, C; Izumi, M; Kawagashira, Y; Koide, H; Nakashima, K; Niwa, JI; Ogawa, K; Oiwa, H; Okada, Y; Taguchi, S; Tokui, K; Tsunoda, Y; Yasumoto, A; Yuasa, T | 1 |
| Atik, H; Ferraiolo, M; Hanson, J; Hermans, E; Koener, B; Ponthot, R | 1 |
| Gencler, OS; Oztekin, MF; Oztekin, N | 1 |
| Ferraiolo, M; Hermans, E | 1 |
50 review(s) available for pramipexole and ropinirole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Second generation of dopamine agonists: pros and cons.
Topics: Antiparkinson Agents; Benzothiazoles; Cabergoline; Dopamine Agonists; Drugs, Investigational; Ergolines; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles | 1995 |
New pharmacotherapy for Parkinson's disease.
Topics: Benzophenones; Benzothiazoles; Cabergoline; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agonists; Enzyme Inhibitors; Ergolines; Humans; Indoles; Nitriles; Nitrophenols; Parkinson Disease; Pramipexole; Receptors, Dopamine D2; Thiazoles; Tolcapone | 1997 |
New options for treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Benzophenones; Benzothiazoles; Cabergoline; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Enzyme Inhibitors; Ergolines; Guidelines as Topic; Humans; Indoles; Nitriles; Nitrophenols; Parkinson Disease; Pramipexole; Thiazoles; Tolcapone; Treatment Outcome | 1997 |
Clinical pharmacology of dopamine agonists in Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Ergot Alkaloids; Humans; Indoles; Neuroprotective Agents; Parkinson Disease; Pramipexole; Thiazoles | 1998 |
Dopamine agonists.
Topics: Apomorphine; Benzothiazoles; Bromocriptine; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Receptors, Dopamine; Thiazoles; Treatment Outcome | 1999 |
Ropinirole and pramipexole, the new agonists.
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Binding, Competitive; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Receptors, Dopamine; Thiazoles | 1999 |
The initial treatment of Parkinson's disease should begin with levodopa.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors | 1999 |
Treatment of Parkinson's disease should begin with a dopamine agonist.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles | 1999 |
Clinical pharmacology of dopamine agonists.
Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Drug Interactions; Ergolines; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles | 2000 |
New drugs for the treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Benzophenones; Benzothiazoles; Cabergoline; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Drug Synergism; Enzyme Inhibitors; Ergolines; Humans; Indoles; Levodopa; Nitrophenols; Parkinson Disease; Pramipexole; Thiazoles; Tolcapone | 2000 |
Waking up to sleep episodes in Parkinson's disease.
Topics: Antiparkinson Agents; Automobile Driving; Benzothiazoles; Dopamine Agents; Humans; Indoles; Narcolepsy; Parkinson Disease; Pramipexole; Risk Factors; Thiazoles | 2000 |
["Sleep attacks" in Parkinson patients. A side effect of nonergoline dopamine agonists or a class effect of dopamine agonists?].
Topics: Accidents, Traffic; Automobile Driving; Benzothiazoles; Contraindications; Dopamine Agents; Dopamine Agonists; Germany; Humans; Indoles; Legislation, Drug; Levodopa; Narcolepsy; Parkinson Disease; Pramipexole; Thiazoles | 2000 |
Possible applications for dopaminergic agents following traumatic brain injury: part 2.
Topics: Amantadine; Benzophenones; Benzothiazoles; Brain Injuries; Catechols; Dopamine Agents; Humans; Indoles; Neuroprotective Agents; Nitriles; Nitrophenols; Patient Selection; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2001 |
Newer dopamine agonists in the treatment of restless legs syndrome.
Topics: Benzothiazoles; Clinical Trials as Topic; Dopamine Agonists; Female; Humans; Indoles; Male; Pramipexole; Restless Legs Syndrome; Thiazoles | 2001 |
Are dopamine receptor agonists neuroprotective in Parkinson's disease?
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Bromocriptine; Cell Culture Techniques; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Models, Animal; Neuroprotective Agents; Parkinson Disease; Pergolide; Pramipexole; Substantia Nigra; Thiazoles | 2001 |
Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.
Topics: Antiparkinson Agents; Benzothiazoles; Disorders of Excessive Somnolence; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; MEDLINE; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Risk Factors; Thiazoles | 2001 |
Two advances in the management of Parkinson disease.
Topics: Age Factors; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dyskinesias; Electric Stimulation Therapy; Forecasting; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Risk Factors; Stereotaxic Techniques; Thiazoles | 2002 |
[Use of dopamine agonists in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors | 2002 |
Sleep attacks--facts and fiction: a critical review.
Topics: Antiparkinson Agents; Benzothiazoles; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles | 2003 |
Do dopamine agonists or levodopa modify Parkinson's disease progression?
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Dihydroxyphenylalanine; Disease Progression; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; Indoles; Iodine Radioisotopes; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tropanes | 2002 |
Dopamine agonist monotherapy in Parkinson's disease.
Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Neuroprotection in idiopathic Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Cell Death; Dopamine Agonists; Humans; Indoles; Levodopa; Neuroprotective Agents; Parkinson Disease; Pramipexole; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Comparison of the risk of adverse events with pramipexole and ropinirole in patients with Parkinson's disease: a meta-analysis.
Topics: Adverse Drug Reaction Reporting Systems; Benzothiazoles; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Risk Assessment; Thiazoles | 2003 |
Dopamine agonist therapy for hyperprolactinemia.
Topics: Aminoquinolines; Benzothiazoles; Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Ergoloid Mesylates; Female; Humans; Hyperprolactinemia; Indoles; Pergolide; Pramipexole; Thiazoles | 2003 |
Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison.
Topics: Age of Onset; Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Evidence-Based Medicine; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles | 2003 |
Sleep attacks in patients receiving dopamine-receptor agonists.
Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pergolide; Pramipexole; Restless Legs Syndrome; Thiazoles | 2005 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Present and future drug treatment for Parkinson's disease.
Topics: Benzothiazoles; Corpus Striatum; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Indans; Indoles; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Pramipexole; Psychomotor Performance; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Substantia Nigra; Thiazoles; Urinary Incontinence | 2005 |
Restless legs syndrome: nonpharmacologic and pharmacologic treatments.
Topics: Amines; Anemia, Iron-Deficiency; Anticonvulsants; Benzothiazoles; Clonazepam; Cyclohexanecarboxylic Acids; Dopamine Agents; Dopamine Agonists; Ferritins; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Iron; Levodopa; Pramipexole; Restless Legs Syndrome; Trace Elements | 2007 |
Restless legs syndrome in older adults.
Topics: Aged, 80 and over; Benzothiazoles; Cabergoline; Circadian Rhythm; Cognition Disorders; Comorbidity; Diagnosis, Differential; Dopamine Agonists; Ergolines; Humans; Indoles; Polysomnography; Pramipexole; Prevalence; Restless Legs Syndrome; Sleep Wake Disorders | 2008 |
Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.
Topics: Benzothiazoles; Dopamine Agonists; Drug-Related Side Effects and Adverse Reactions; Humans; Indoles; Multicenter Studies as Topic; Pramipexole; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Treatment Outcome | 2008 |
Internal medicine: guidance to the diagnosis and management of restless legs syndrome.
Topics: Benzothiazoles; Critical Pathways; Cross-Sectional Studies; Dopamine Agonists; Humans; Indoles; Internal Medicine; Levodopa; Polysomnography; Pramipexole; Primary Health Care; Restless Legs Syndrome; Risk Factors; Treatment Outcome | 2008 |
Restless legs syndrome in women: a review.
Topics: Benzothiazoles; Diagnosis, Differential; Dopamine Agonists; Female; Humans; Indoles; Life Style; Pramipexole; Quality of Life; Randomized Controlled Trials as Topic; Restless Legs Syndrome; United States; Women's Health | 2008 |
Treatment options for restless legs syndrome.
Topics: Benzothiazoles; Dopamine Agonists; Humans; Indoles; Levodopa; Pramipexole; Restless Legs Syndrome | 2009 |
Critical review of ropinirole and pramipexole - putative dopamine D(3)-receptor selective agonists - for the treatment of RLS.
Topics: Animals; Benzothiazoles; Clinical Trials as Topic; Diagnosis, Differential; Dopamine; Dopamine Agonists; Humans; Indoles; Pramipexole; Receptors, Dopamine D3; Restless Legs Syndrome | 2009 |
[Clinical data of the prolonged-release formulation of ropinirole].
Topics: Antiparkinson Agents; Benzothiazoles; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Quality of Life | 2010 |
Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole | 2011 |
Indirect comparisons of adverse events and dropout rates in early Parkinson's disease trials of pramipexole, ropinirole, and rasagiline.
Topics: Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cross-Sectional Studies; Databases, Bibliographic; Fatigue; Female; Gastrointestinal Diseases; Humans; Indans; Indoles; Logistic Models; Male; Parkinson Disease; Patient Dropouts; Pramipexole; Sleep Wake Disorders; Treatment Outcome | 2012 |
ADMET considerations for restless leg syndrome drug treatments.
Topics: Amines; Anticonvulsants; Benzothiazoles; Carbamates; Cyclohexanecarboxylic Acids; Dopamine Agents; Dopamine Agonists; Ergolines; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Levodopa; Neuralgia; Pramipexole; Pregabalin; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2012 |
The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline.
Topics: Academies and Institutes; Benzothiazoles; Cabergoline; Carbamates; Dopamine Agents; Ergolines; Evidence-Based Medicine; gamma-Aminobutyric Acid; Humans; Indoles; Levodopa; Nocturnal Myoclonus Syndrome; Pergolide; Peripheral Nervous System Diseases; Pramipexole; Restless Legs Syndrome; Sleep Medicine Specialty; United States; Venous Insufficiency | 2012 |
Anti-Parkinson's disease drugs and pharmacogenetic considerations.
Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline | 2013 |
The impact of restless legs syndrome: a familial case study.
Topics: Adult; Analgesics, Opioid; Anticonvulsants; Benzodiazepines; Benzothiazoles; Carbidopa; Dopamine Agonists; Drug Combinations; Family Health; Humans; Incidence; Indoles; Levodopa; Male; Middle Aged; Pramipexole; Prevalence; Restless Legs Syndrome | 2013 |
Meta-analysis of the efficacy and safety of long-acting non-ergot dopamine agonists in Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Drug Delivery Systems; Humans; Indoles; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Statistics, Nonparametric | 2014 |
Restless legs syndrome: clinical presentation diagnosis and treatment.
Topics: Amines; Analgesics, Opioid; Benzothiazoles; Cyclohexanecarboxylic Acids; Dopamine Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Methadone; Pramipexole; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2015 |
Clinical management of restless legs syndrome in end-stage renal disease patients.
Topics: Amines; Analgesics, Opioid; Benzodiazepines; Benzothiazoles; Comorbidity; Cyclohexanecarboxylic Acids; Dopamine Agonists; Excitatory Amino Acid Antagonists; Exercise Therapy; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Intermittent Pneumatic Compression Devices; Kidney Failure, Chronic; Levodopa; Massage; Pramipexole; Quality of Life; Renal Dialysis; Restless Legs Syndrome; Sleep Hygiene; Tetrahydronaphthalenes; Thiophenes | 2017 |
Comparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson's Disease: A Network Meta-Analysis.
Topics: Bromocriptine; Cluster Analysis; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; Network Meta-Analysis; Parkinson Disease; Picolinic Acids; Pramipexole; Selegiline; Tetrahydronaphthalenes; Thiophenes | 2017 |
Indirect Comparison of Ropinirole and Pramipexole as Levodopa Adjunctive Therapy in Advanced Parkinson's Disease: A Systematic Review and Network Meta-Analysis.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Combined Modality Therapy; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole | 2019 |
Rotigotine Transdermal Patch: A Review in Parkinson's Disease.
Topics: Administration, Cutaneous; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Quality of Life; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2019 |
The complex molecular pharmacology of the dopamine D
Topics: Antiparkinson Agents; Dopamine; Dopamine Agonists; Humans; Pramipexole; Receptors, Dopamine | 2023 |
16 trial(s) available for pramipexole and ropinirole
| Article | Year |
|---|---|
Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series.
Topics: Adult; Aged; Benzothiazoles; Bipolar Disorder; Depressive Disorder; Dopamine Agonists; Drug Resistance; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Pramipexole; Psychiatric Status Rating Scales; Thiazoles | 2001 |
Combination of two different dopamine agonists in the management of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Thiazoles; Treatment Outcome | 2002 |
Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison.
Topics: Age of Onset; Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Evidence-Based Medicine; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles | 2003 |
Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pilot Projects; Pramipexole; Thiazoles | 2004 |
Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study.
Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Double-Blind Method; Echocardiography; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Hypertrophy, Left Ventricular; Indoles; Male; Middle Aged; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Tricuspid Valve Insufficiency | 2007 |
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease.
Topics: Benzothiazoles; Dopamine Agonists; Double-Blind Method; Endpoint Determination; Female; Humans; Indoles; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pramipexole; Severity of Illness Index; Time Factors | 2006 |
An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease.
Topics: Accidental Falls; Aged; Antiparkinson Agents; Benzothiazoles; Cohort Studies; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Patient Satisfaction; Pramipexole | 2009 |
Pramipexole versus ropinirole: polysomnographic acute effects in restless legs syndrome.
Topics: Adult; Aged; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Polysomnography; Pramipexole; Prospective Studies; Restless Legs Syndrome; Statistics as Topic | 2011 |
Effect of chronic kidney disease on excessive daytime sleepiness in Parkinson disease.
Topics: Aged; Benzothiazoles; Comorbidity; Disorders of Excessive Somnolence; Dopamine Agonists; Female; Humans; Indoles; Kidney Diseases; Male; Middle Aged; Parkinson Disease; Pramipexole | 2011 |
Dopaminergic drug-induced modulation of the expression of the dopamine transporter in peripheral blood lymphocytes in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Drug Combinations; Female; Flow Cytometry; Gene Expression Regulation; Humans; Indoles; Levodopa; Lymphocytes; Male; Middle Aged; Parkinson Disease; Pramipexole | 2011 |
Comparison of once-daily versus twice-daily combination of ropinirole prolonged release in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Drug Administration Schedule; Female; Humans; Indoles; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Retrospective Studies; Surveys and Questionnaires | 2013 |
Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease.
Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Delayed-Action Preparations; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Polysomnography; Pramipexole; Restless Legs Syndrome; Sleep Stages; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2014 |
Switch from oral pramipexole or ropinirole to rotigotine transdermal system in advanced Parkinson's disease: an open-label study.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Drug Substitution; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Tetrahydronaphthalenes; Thiophenes | 2015 |
Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study.
Topics: Activities of Daily Living; Administration, Cutaneous; Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes | 2015 |
Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Combinations; Drug Substitution; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole | 2019 |
Comparison of pramipexole versus ropinirole in the treatment of Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Humans; Indoles; Middle Aged; Neurodegenerative Diseases; Parkinson Disease; Pramipexole | 2022 |
92 other study(ies) available for pramipexole and ropinirole
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Design and synthesis of a functionally selective D3 agonist and its in vivo delivery via the intranasal route.
Topics: Administration, Intranasal; Animals; Crystallography, X-Ray; Dogs; Dopamine Agonists; Drug Design; Humans; Models, Molecular; Molecular Structure; Rats; Receptors, Dopamine D3; Stereoisomerism; Structure-Activity Relationship | 2007 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Modification of agonist binding moiety in hybrid derivative 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-1-ol/-2-amino versions: impact on functional activity and selectivity for dopamine D2/D3 receptors.
Topics: Animals; CHO Cells; Cricetulus; Dopamine Agonists; Guanosine 5'-O-(3-Thiotriphosphate); HEK293 Cells; Humans; Kinetics; Naphthalenes; Piperazines; Protein Binding; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; Spiperone; Structure-Activity Relationship | 2013 |
Synthesis and binding affinity of new 1,4-disubstituted triazoles as potential dopamine D(3) receptor ligands.
Topics: Click Chemistry; Dopamine D2 Receptor Antagonists; Humans; Kinetics; Ligands; Piperazines; Protein Binding; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Triazoles | 2013 |
Hydroxy-Substituted Heteroarylpiperazines: Novel Scaffolds for β-Arrestin-Biased D
Topics: Animals; beta-Arrestins; CHO Cells; Cricetulus; Dopamine Agonists; Humans; Piperazines; Receptors, Dopamine D2 | 2017 |
New dopamine agonists on the horizon.
Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles | 1997 |
Assessment of potential interactions between dopamine receptor agonists and various human cytochrome P450 enzymes using a simple in vitro inhibition screen.
Topics: Benzothiazoles; Bromocriptine; Cytochrome P-450 Enzyme Inhibitors; Dopamine Agonists; Enzyme Inhibitors; Humans; Indoles; Pergolide; Pramipexole; Thiazoles | 1997 |
Pramipexole and ropinirole for Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles | 1997 |
New anti-parkinsonian drugs.
Topics: Antiparkinson Agents; Benzophenones; Benzothiazoles; Humans; Indoles; Levodopa; Nitrophenols; Parkinson Disease; Pramipexole; Thiazoles; Tolcapone | 1998 |
Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Sleep; Thiazoles; Wakefulness | 1999 |
'Sleep attacks' attributed to new antiparkinsonian drugs.
Topics: Antiparkinson Agents; Benzothiazoles; Humans; Indoles; Narcolepsy; Pramipexole; Thiazoles; United States | 1999 |
Several classes of new drugs emerging for Parkinson disease.
Topics: Antiparkinson Agents; Benzothiazoles; Catechol O-Methyltransferase Inhibitors; Catechols; Dopamine Agonists; Enzyme Inhibitors; Humans; Indoles; Levodopa; Nitriles; Parkinson Disease; Pramipexole; Thiazoles | 1999 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole.
Topics: Accidents, Traffic; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Humans; Indoles; Pramipexole; Sleep; Thiazoles | 2000 |
Non-ergot dopamine agonist-induced sleep attacks.
Topics: Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Thiazoles | 2000 |
Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Drug Administration Schedule; Female; Humans; Hypotension, Orthostatic; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Thiazoles | 2000 |
Comparative effects of repeated administration of dopamine agonists on circling behavior in rats.
Topics: Animals; Benzothiazoles; Brain; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Indoles; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Thiazoles | 2000 |
[Dopaminergic agonists in the treatment of Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles | 2000 |
Antiparkinsonian drugs and "sleep attacks".
Topics: Adverse Drug Reaction Reporting Systems; Aged; Antiparkinson Agents; Automobile Driving; Benzothiazoles; Canada; Humans; Indoles; Parkinson Disease; Pramipexole; Sleep Wake Disorders; Thiazoles | 2001 |
Efficacy and tolerability of dopamine agonists in a parkinsonian population.
Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome | 2001 |
Alopecia induced by dopamine agonists.
Topics: Aged; Alopecia; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Female; Humans; Indoles; Parkinson Disease; Pramipexole; Thiazoles | 2002 |
The initial drug treatment of older patients with Parkinson's disease - consider an agonist, but don't demonise dopa.
Topics: Antiparkinson Agents; Benzothiazoles; Catechol O-Methyltransferase; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Thiazoles | 2003 |
REAL and CALM: what have we learned?
Topics: Antiparkinson Agents; Benzothiazoles; Clinical Trials as Topic; Corpus Striatum; Disease Progression; Dopamine; Feasibility Studies; Humans; Indoles; Levodopa; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Putamen; Reference Values; Sensitivity and Specificity; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole.
Topics: Adenylyl Cyclases; Animals; Antiparkinson Agents; Benzothiazoles; Binding, Competitive; Colforsin; COS Cells; Dimerization; Enzyme Activation; Humans; Indoles; Ligands; Nucleus Accumbens; Oxazines; Pertussis Toxin; Pramipexole; Protein Binding; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Transfection | 2003 |
Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Benzothiazoles; Cell Count; Cell Line; DNA; Dopamine Agents; Dopamine Agonists; Humans; Immunohistochemistry; Indoles; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxazines; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrazolium Salts; Thiazoles | 2003 |
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
Topics: Aged; Benzothiazoles; Bromocriptine; Disorders of Excessive Somnolence; Dopamine Agonists; Dose-Response Relationship, Drug; Ergot Alkaloids; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Polysomnography; Pramipexole; Prospective Studies; Sleep; Thiazoles; Wakefulness | 2004 |
Slowing Parkinson's disease progression: recent dopamine agonist trials.
Topics: Antiparkinson Agents; Benzothiazoles; Biological Transport; Cell Line, Tumor; Clinical Trials as Topic; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; In Vitro Techniques; Indoles; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuroblastoma; Parkinson Disease; Pramipexole; Thiazoles | 2004 |
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles | 2004 |
Predictors of sudden onset of sleep in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Comorbidity; Cross-Sectional Studies; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pramipexole; Risk Factors; Surveys and Questionnaires; Thiazoles | 2004 |
Calming restless legs.
Topics: Analgesics, Opioid; Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Humans; Indoles; Nocturnal Myoclonus Syndrome; Pramipexole; Restless Legs Syndrome; Thiazoles; Wakefulness | 2004 |
"Levodopa phobia": a new iatrogenic cause of disability in Parkinson disease.
Topics: Aged; Amantadine; Benzothiazoles; Catechols; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Iatrogenic Disease; Indoles; Levodopa; Male; Middle Aged; Neurology; Neuropharmacology; Neurotoxicity Syndromes; Nitriles; Parkinson Disease; Pramipexole; Selegiline; Thiazoles; Treatment Outcome | 2005 |
Pramipexole, ropinirole, and mania in Parkinson's disease.
Topics: Adult; Antiparkinson Agents; Benzothiazoles; Bipolar Disorder; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles | 2005 |
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Catechols; Databases, Factual; Dopamine Agonists; Humans; Indoles; Levodopa; Male; Mental Disorders; Middle Aged; Multiple System Atrophy; Nitriles; Parkinson Disease; Pramipexole; Sexual Dysfunctions, Psychological; Thiazoles | 2005 |
Pathological gambling in Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Brain; Dopamine Agonists; Dose-Response Relationship, Drug; Gambling; Humans; Indoles; Mental Disorders; Neural Pathways; Parkinson Disease; Pramipexole; Thiazoles | 2005 |
Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons.
Topics: Animals; Astrocytes; Benzothiazoles; Blotting, Western; Brain-Derived Neurotrophic Factor; Cell Count; Cells, Cultured; Culture Media, Conditioned; Dopamine; Dopamine Agonists; Enzyme-Linked Immunosorbent Assay; Female; Glial Cell Line-Derived Neurotrophic Factor; Immunohistochemistry; Indoles; Mesencephalon; Neurons; Pramipexole; Pregnancy; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles; Tyrosine 3-Monooxygenase | 2005 |
Association of dopamine agonist use with impulse control disorders in Parkinson disease.
Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Follow-Up Studies; Gambling; Humans; Indoles; Logistic Models; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Risk Factors; Sexual Behavior; Sexual Dysfunction, Physiological; Thiazoles | 2006 |
[Dopamine agonists for treatment of restless leg syndrome].
Topics: Benzothiazoles; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Pramipexole; Restless Legs Syndrome; Thiazoles | 2006 |
Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Case-Control Studies; Echocardiography; Female; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole | 2007 |
Discontinuation of ropinirole and pramipexole in patients with Parkinson's disease: clinical practice versus clinical trials.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Cohort Studies; Female; Follow-Up Studies; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Patient Compliance; Practice Guidelines as Topic; Pramipexole; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome | 2008 |
Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.
Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Echocardiography; Female; Heart Valve Diseases; Heart Valves; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole | 2008 |
Cost-effectiveness of licensed treatment options for restless legs syndrome in the UK and Sweden.
Topics: Benzothiazoles; Costs and Cost Analysis; Dopamine Agonists; Female; Humans; Indoles; Male; Markov Chains; Models, Theoretical; Pramipexole; Restless Legs Syndrome; Sweden; United Kingdom | 2008 |
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States | 2009 |
[Impulse control disorder induced by the use of dopamine agonists].
Topics: Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Restless Legs Syndrome; Risk Factors | 2009 |
Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.
Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Carbidopa; Compulsive Behavior; Dopamine Agonists; Female; Gambling; Humans; Indoles; Levodopa; Libido; Male; Middle Aged; Parkinson Disease; Pramipexole; Retrospective Studies | 2009 |
Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients.
Topics: Adult; Avoidance Learning; Benzothiazoles; Cross-Sectional Studies; Dopamine Agonists; Exploratory Behavior; Feedback, Psychological; Female; Follow-Up Studies; Humans; Indoles; Learning; Male; Middle Aged; Parkinson Disease; Personality; Personality Assessment; Pramipexole; Reward | 2009 |
[Socioeconomic relevance of the idiopathic restless legs syndrome (RLS) in Germany: cost-of-illness study].
Topics: Benzothiazoles; Delayed-Action Preparations; Dopamine Agents; Dopamine Agonists; Drug Costs; Financing, Personal; Germany; Health Care Costs; Humans; Indoles; Levodopa; Long-Term Care; Markov Chains; Models, Economic; National Health Programs; Practice Guidelines as Topic; Pramipexole; Resource Allocation; Restless Legs Syndrome; Socioeconomic Factors; Treatment Outcome | 2009 |
Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease.
Topics: Aged; Alleles; Benzothiazoles; Cohort Studies; Contraindications; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pharmacogenetics; Polymorphism, Single Nucleotide; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2009 |
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Comorbidity; Disability Evaluation; Dopamine Agonists; Female; Gastrointestinal Diseases; Humans; Indoles; Levodopa; Male; Memory Disorders; Middle Aged; Mood Disorders; Movement Disorders; Neurologic Examination; Nocturia; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Prevalence; Restless Legs Syndrome; Treatment Outcome | 2009 |
Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study.
Topics: Adult; Aged; Benzothiazoles; Case-Control Studies; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Female; Humans; Indoles; Male; Middle Aged; Pramipexole; Prospective Studies; Restless Legs Syndrome; Sleep Apnea, Obstructive | 2010 |
Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
Topics: Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Impulsive Behavior; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Schizophrenia, Paranoid; Smoking | 2010 |
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Binge-Eating Disorder; Comorbidity; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Female; Gambling; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Prevalence; Risk Factors; Sexual Dysfunctions, Psychological | 2010 |
Isolated delusional syndrome in Parkinson's Disease.
Topics: Aged; Amantadine; Antiparkinson Agents; Benserazide; Benzothiazoles; Catechols; Clonazepam; Female; Humans; Indans; Indoles; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Pramipexole; Schizophrenia, Paranoid; Syndrome | 2010 |
Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Compulsive Behavior; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole | 2011 |
Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample.
Topics: Adult; Aged; Benzothiazoles; Cross-Sectional Studies; Dopamine Agonists; Female; Health Surveys; Humans; Indoles; Levodopa; Male; Middle Aged; Outpatients; Patient Satisfaction; Pergolide; Pramipexole; Restless Legs Syndrome; Risk Factors; Treatment Failure | 2011 |
Acupuncture for restless legs syndrome in patients previously treated with dopaminergic drugs.
Topics: Acupuncture Therapy; Adult; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agents; Humans; Indoles; Male; Pramipexole; Restless Legs Syndrome; Retrospective Studies | 2011 |
Breakthrough symptoms during the daytime in patients with restless legs syndrome (Willis-Ekbom disease).
Topics: Adult; Aged; Benzothiazoles; Circadian Rhythm; Clonazepam; Cross-Sectional Studies; Dopamine Agonists; Female; GABA Modulators; Health Surveys; Humans; Indoles; Male; Middle Aged; Pramipexole; Prevalence; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2012 |
Spontaneous unwelcome orgasms due to pramipexole and ropinirole.
Topics: Antiparkinson Agents; Benzothiazoles; Female; Humans; Indoles; Middle Aged; Nervous System Diseases; Orgasm; Parkinson Disease; Pramipexole | 2012 |
Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Confidence Intervals; Disorders of Excessive Somnolence; Disruptive, Impulse Control, and Conduct Disorders; Dizziness; Dopamine Agonists; Drug Therapy, Combination; Female; Hallucinations; Humans; Indoles; Kaplan-Meier Estimate; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Time Factors | 2012 |
Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy.
Topics: Adult; Amantadine; Antiparkinson Agents; Benzothiazoles; Carbidopa; Catechols; Disruptive, Impulse Control, and Conduct Disorders; Drug Combinations; Female; Humans; Indans; Indoles; Levodopa; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Pramipexole; Selegiline | 2013 |
Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders.
Topics: Aged, 80 and over; Benzothiazoles; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Substance Withdrawal Syndrome | 2013 |
Second-generation dopamine agonists and recollection impairments in Parkinson's disease.
Topics: Aged; Attention; Benzothiazoles; Case-Control Studies; Dopamine Agonists; Female; Humans; Indoles; Male; Memory Disorders; Memory, Short-Term; Mental Recall; Middle Aged; Parkinson Disease; Pramipexole; Recognition, Psychology | 2013 |
Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.
Topics: Benzothiazoles; Case-Control Studies; Decision Making; Dopamine Agonists; Female; Gambling; Humans; Impulsive Behavior; Indoles; Interview, Psychological; Male; Middle Aged; Neuropsychological Tests; Pramipexole; Prospective Studies; Restless Legs Syndrome; Reward; Surveys and Questionnaires | 2013 |
Two cases of pregnancy in Parkinson's disease.
Topics: Adult; Antiparkinson Agents; Benzothiazoles; Female; Fetus; Humans; Indoles; Parkinson Disease; Pramipexole; Pregnancy; Pregnancy Complications | 2014 |
Treatment of pediatric restless legs syndrome.
Topics: Adolescent; Amines; Analgesics; Anticonvulsants; Antioxidants; Benzothiazoles; Child; Child, Preschool; Clonidine; Cyclohexanecarboxylic Acids; Dopamine Agonists; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Iron; Male; Melatonin; Mental Disorders; Pediatrics; Polysomnography; Pramipexole; Restless Legs Syndrome; Retrospective Studies; Sleep Wake Disorders; Treatment Outcome | 2014 |
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
Topics: Administration, Cutaneous; Administration, Oral; Age Factors; Aged; Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole; Sex Factors; Tetrahydronaphthalenes; Thiophenes | 2014 |
A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
Topics: Adult; Aged; Bayes Theorem; Benzothiazoles; Carbamates; Dopamine Agonists; Female; gamma-Aminobutyric Acid; Humans; Indoles; Male; Middle Aged; Pramipexole; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2014 |
Augmentation in restless legs syndrome patients in Korea.
Topics: Aged; Aged, 80 and over; Amines; Benzothiazoles; Cross-Sectional Studies; Cyclohexanecarboxylic Acids; Disease Progression; Dopamine Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Korea; Long-Term Care; Male; Middle Aged; Pramipexole; Pregabalin; Restless Legs Syndrome; Risk Factors | 2015 |
Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
Topics: Adult; Aged; Aripiprazole; Benzothiazoles; Compulsive Behavior; Consumer Behavior; Dopamine Agonists; Drug Labeling; Female; Gambling; Humans; Hyperprolactinemia; Impulsive Behavior; Indoles; Male; Middle Aged; Parkinson Disease; Piperazines; Pramipexole; Quinolones; Receptors, Dopamine D3; Restless Legs Syndrome; Retrospective Studies; Sexual Behavior; United States; United States Food and Drug Administration | 2014 |
The link between non-ergot-derived dopamine agonists and heart failure: how strong is it?
Topics: Benzothiazoles; Dopamine Agonists; Heart Failure; Humans; Indoles; Pramipexole | 2015 |
Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson's Disease: A Prospective, Cross-Sectional Study in Non-demented Patients.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Apathy; Benzothiazoles; Cross-Sectional Studies; Dopamine Agonists; Educational Status; Female; Humans; Indoles; Levodopa; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Parkinson Disease; Pramipexole; Prospective Studies; Psychotropic Drugs; Spain | 2015 |
Duration of drug action of dopamine D2 agonists in mice with 6-hydroxydopamine-induced lesions.
Topics: Animals; Antiparkinson Agents; Apomorphine; Azepines; Benzothiazoles; Cabergoline; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Ergolines; Indoles; Injections, Intraventricular; Male; Mice; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pramipexole; Quinolines; Receptors, Dopamine D2; Tetrahydronaphthalenes; Thiophenes | 2015 |
Validated UHPLC-MS/MS method for the simultaneous determination of pramipexole and ropinirole in plasma of patients with Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Chromatography, High Pressure Liquid; Humans; Indoles; Parkinson Disease; Pramipexole; Tandem Mass Spectrometry | 2016 |
A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists.
Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Surveys and Questionnaires | 2016 |
A method to switch from oral dopamine agonists to rotigotine in patients with restless legs syndrome and mild augmentation.
Topics: Administration, Oral; Aged; Benzothiazoles; Dopamine Agonists; Drug Synergism; Female; Humans; Indoles; Male; Pramipexole; Restless Legs Syndrome; Severity of Illness Index; Tetrahydronaphthalenes; Thiophenes; Time Factors; Transdermal Patch | 2016 |
Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Canada; Case-Control Studies; Cohort Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug-Related Side Effects and Adverse Reactions; Female; Gambling; Humans; Indoles; Male; Middle Aged; Pramipexole | 2017 |
Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.
Topics: Adult; Age of Onset; Aged; Behavior, Addictive; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Pramipexole; Receptors, Dopamine D3 | 2018 |
Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndrome.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Analgesics; Dopamine Agonists; Female; Gabapentin; Humans; Indoles; Male; Medication Adherence; Middle Aged; Pramipexole; Restless Legs Syndrome; Retrospective Studies | 2018 |
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling.
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Brain-Derived Neurotrophic Factor; Dopaminergic Neurons; Humans; Indoles; Induced Pluripotent Stem Cells; Mice; Neuronal Plasticity; Pramipexole; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |
Hair-pulling disorder complicated by skin-picking disorder: An unknown side-effect of dopamine replacement therapy?
Topics: Benzothiazoles; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Indans; Indoles; Middle Aged; Monoamine Oxidase Inhibitors; Pramipexole; Self-Injurious Behavior; Trichotillomania | 2018 |
Drug-induced gambling disorder: A not so rare but underreported condition.
Topics: Aged; Aged, 80 and over; Dopamine Agonists; Gambling; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pramipexole | 2018 |
Assessment of change in restless legs syndrome symptoms during the acute drug-withdrawal period.
Topics: Analgesics; Analgesics, Opioid; Dopamine Agonists; Electromyography; Female; Gabapentin; Humans; Indoles; Male; Middle Aged; Oxycodone; Polysomnography; Pramipexole; Restless Legs Syndrome; Substance Withdrawal Syndrome | 2018 |
Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Delayed-Action Preparations; Dopamine Agonists; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Sex Factors; Tetrahydronaphthalenes; Thiophenes | 2019 |
What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans; Iatrogenic Disease; Indoles; Male; Middle Aged; Parkinson Disease; Pramipexole; Selective Serotonin Reuptake Inhibitors | 2020 |
Increased risk for developing gambling disorder under the treatment with pramipexole, ropinirole, and aripiprazole: A nationwide register study in Sweden.
Topics: Adult; Aged; Aged, 80 and over; Aripiprazole; Behavior, Addictive; Cross-Sectional Studies; Dopamine; Dopamine Agonists; Female; Gambling; Humans; Indoles; Male; Middle Aged; Pramipexole; Registries; Reward; Risk Factors; Sweden; Young Adult | 2021 |
Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Cross-Sectional Studies; Dopamine Agonists; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Regression Analysis; Retrospective Studies; Sleep; Tetrahydronaphthalenes; Thiophenes | 2021 |
Dopamine D
Topics: Antiparkinson Agents; beta-Arrestin 2; Biosensing Techniques; Dopamine; Dopamine Agonists; Humans; Indoles; Luciferases; Pramipexole; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Tetrahydronaphthalenes; Thiophenes | 2022 |